UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2019
Commission file number:001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):¨
CONTENETS
Itamar Medical Ltd. (the"Registrant"or the"Company") hereby announces that it will hold its 2019 Annual General Meeting of Shareholders (the“Meeting”) at its executive offices at 9 Halamish Street, Caesarea 3088900, Israel, on Wednesday, May 29, 2019 at 1:00 p.m. (Israel time). Copies of the Company's notice, and proxy statement and proxy card for the meeting, are attached to this Form 6-K as exhibits 99.1 and 99.2 respectively, and incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ITAMAR MEDICAL LTD. | ||
| By: | /s/ Shy Basson | |
| Shy Basson | ||
| Chief Financial Officer | ||
Date: April 23, 2019
Exhibits
| Exhibit Number | Description | ||
| 99.1 | Notice and Proxy Statement for the Company' Annual General Meeting to be held on May 29, 2019. | ||
| 99.2 | Form of Proxy Card to be used in connection with the Company' Annual General Meeting to be held on May 29, 2019. | ||